156
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Cultures of Human Colonic Epithelial Cells Isolated from Endoscopical Biopsies from Patients with Inflammatory Bowel Disease. Effect of IFNγ, TNFα and IL-1β on Viability, Butyrate Oxidation and IL-8 Secretion

, , &
Pages 255-263 | Received 02 Jan 2000, Accepted 05 May 2000, Published online: 07 Jul 2009

References

  • Sartor R B. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533–539
  • D'Haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F., et al. Endoscopical and histological healing with anti-tumor necrosis factor antibodies in Crohn's disease: A european multicenter trial. Gastroenterology 1999; 116: 1029–1034
  • Brynskov J, Nielsen O, Ahnfelt-Rønne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel diseases (Crohn's disease and ulcerative colitis). A review. Dig Dis 1994; 12: 290–304
  • Bendtzen K. Cytokines and natural regulators of cytokines. Immunol Lett 1994; 43: 111–123
  • Deem R L, Shanahan F, Targan S R. Triggered human mucosal T-cells release tumour necrosis factor-alfa and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol 1991; 83: 79–84
  • Radford-Smith G, Jewel D P. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 1996; 10: 151–164
  • Plevy S, Landers C, Prehn J, Carramanzana N M, Deem R L, Shearly D., et al. A role for TNFα and mucosal T helper! cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159: 6276–6282
  • Schreiber S, Nikolaus S, Hampe J, Hamling J, Koop I, Groessner B., et al. Tumour necrosis factor alpha and inter-leukin 1 beta in relapse of Crohn's disease. Lancet 1999; 353: 459–461
  • McKay D M, Baird A. Cytokine regulation of epithelial permeability and ion transport. Gut 1999; 44: 283–289
  • Fiocchi C. Inflammatory Bowel Disease: Etiology and pathogenesis. Gastroenterology 1998; 115: 182–205
  • Di Paolo M C, Merrett M N, Crotty B, Jewel D P. 5-aminosali-cylic acid inhibits the impaired epithelial barrier function induced by gamma interferron. Gut 1996; 38: 115–119
  • Mahraoui L, Heyman M, Plique M T, Desjeux J F. Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alfa. Gut 1997; 40: 339–343
  • Madara J L, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989; 83: 724–727
  • Jarry A, Muzeau F, Laboisse C. Cytokine effects in a human colonic colonic goblet cell line. Dig Dis Sei 1992; 37: 1170–1178
  • Pedersen G, Saermark T, Bendtzen K, Giese B, Horn T, Brynskov J. Cytokine-induced damage to human colonic epithelial cells: viability and metabolism. Scan J Immunol 1998; 47: A 34
  • Pedersen G, Saermark T, Bendtzen K, Giese B, Horn T, Brynskov J. Cytokine-induced impairment of short chain fatty acid oxidation and viability in two human colonic epithelial cell lines. Cytokine, (in press)
  • Pedersen G, Saermark T, Giese B, Hansen A, Drag B, Brynskov J. A simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopical biopsies. Scand J Gastroenterol, (in press)
  • MacDermott R P, Sanderson I, Reinecker H. The central role of chemokines (chemotactic cytokines) in the immunopatho-genesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998; 4: 54–67
  • Langholz E, Munkholm P, Davidson M, Binder V. Couse of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3–11
  • Munkholm P, Langholz E, Nielsen O, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: A sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609–614
  • Liu Y, Peterson D A, Kimura H. Schubert D. Mechanism of cellular 3-(4,5-dimethylfhiazol-2-yl)-2,5-diphenyltetrazo-lium bromide (MTT) reduction. J Neuwchem 1997; 69: 581–593
  • Christ A, Blumberg R. The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol 1997; 18: 449–461
  • McKay D M, Philpott D J, Perdue M H. In vitro models in inflammatory bowel disease research - a critical review. Aliment Pharmacol Ther 1997; 11: 70–80
  • Dwinell M B, Eckmann L, Leopard J D, Varki N M, Kagnoff M F. Chemokine receptor expression by human intestinale epithelial cells. Gastroenterology 1999; 117: 359–367
  • Madsen K, Lewis S A, Tavernini M M, Hibbard J, Fedorak R N. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 1997; 113: 151–159
  • Xu X, Fu X, Plate J, Chong A. IFN-y induced cell growth inhibition by Fas-mediated apoptosis: Requirement of Statl protein for upregulation of Fas and FasL expression. Cancer Res 1998; 58: 2832–2837
  • Ossina N, Cannas A, Powers V, Fitzpatrick P A, Knight J D, Gilbert J. R., et al. Interferon-y modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997; 272: 16351–16357
  • Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen J, Din-Arello C., Svenson M. Cytotoxicity of human pi 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
  • Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune fheumatic diseases and endocrine diseases. Autoimmunity 1989; 22: 177–189
  • Reimund J M, Wittersheim C, Dumont S, et al. Increased production of tumor necrosis factor alfa, interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996; 39: 684–689
  • Gibson P R, Barkla D H. Mucosal metabolism and proliferation. Inflammatory Bowel Disease 3 Edn., R N Allan, J M Rhodes, S B Hanauer, M RB Keighley, J Alexander-Williams, V W Fazio. Churchill-Livingstone, New York 1997; 201–214
  • Musch M, Ciancio M, Sarge K, Chang E. Induction of heat shock protein 70 protects intestinal epithelial IEC-18 cells from oxidant and thermal injury. Am J Phwsiol 1996; 270: C429–C436
  • Clausen M R, Mortensen P B. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 1995; 37: 684–689
  • Roedinger W. The colonic epithelium in ulcerative colitis: an energy defiency disease?. Lancet 1980; 21: 793–798
  • Finnie I A, Taylor B A, Rhodes J M. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut 1993; 34: 1552–1558
  • Simpson E, Chapman M, Dawson J, Berry I, Macdonald I, Cole A. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut 2000; 46: 73–77
  • Chapman M, Grahn M F, Boyle M A, Hutton M, Rogers J, Williams N S. Butyrate oxidation is impaired in colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994; 35: 73–76
  • Watson A JM, Askew J N, Sandle G I. Characterisation of oxidative injury to an intestinal cell line (HT-29) by hydrogen peroxide. Gut 1994; 35: 1575–1581
  • Schulze-Osthoff K, Bakker A, Vanhaesebroeck B, Beyaert R, Jacobs W A, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem 1992; 267: 5317–5323
  • Allan E S, Winter S, Light A M, Allan A. Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis. Gut 1996; 38: 886–893
  • Gibson P R, Rosella O. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury supressed by butyrate and enhanched in inflammatory bowel disease. Gut 1995; 37: 536–543
  • Warhurst A, Hopkins S, Warhurst G. Interferon y induces differential upregulation of α and β chemokine secretion in colonic epithelial cell line. Cut 1999; 42: 208–213
  • Yang S, Eckmann L, Panja A, Kagnoff M. Differential and regulated expression of C-X-C, C-C and C-chemokines by human colon epithelial cells. Gastroenterology 1997; 113: 1214–1223

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.